Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,300 papers from all fields of science
Search
Sign In
Create Free Account
Parathormone (human recombinant)
Known as:
parathyroid hormone (1-84) human recombinant
, rhPTH
, rhPTH(1-84)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Recombinant parathyroid hormone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Bone Biomechanics and Bone Quality: Effects of Pharmaceutical Agents Used to Treat Osteoporosis
D. Burr
Clinical Reviews in Bone and Mineral Metabolism
2016
Corpus ID: 78366690
The biomechanical properties of bone define skeletal fragility. Surrogates such as bone density or biochemical markers are used…
Expand
Review
2013
Review
2013
Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
Michael Gonzales
,
D. Lieb
,
Donald W. Richardson
,
J. O'brian
,
J. Aloi
,
R. Khardori
Endocrine Practice
2013
Corpus ID: 25348429
OBJECTIVE To describe a case of hypocalcemia in a patient with a gain-of-function mutation in the calcium-sensing receptor that…
Expand
2013
2013
The rhPTH treatment elevates plasma secreted protein acidic and rich in cysteine levels in patients with osteoporosis
L. Zhang
,
L. Li
,
M. Yang
,
K. Xu
,
G. Boden
,
G. Yang
Osteoporosis International
2013
Corpus ID: 25325170
SummaryThe secreted protein acidic and rich in cysteine (SPARC), also known as osteonectin, plays an important role in osteoblast…
Expand
2012
2012
The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
L. Zhang
,
M. Yang
,
D. Liu
,
C. Guo
,
L. Li
,
G. Yang
Experimental and clinical endocrinology…
2012
Corpus ID: 41235712
PURPOSE Intermittent administration of recombinant human PTH [rhPTH (1-34)] exerts an osteoanabolic effect characterized by…
Expand
2012
2012
Changes in serum runt-related transcription factor 2 levels after a 6-month treatment with recombinant human parathyroid hormone in patients with osteoporosis
W. Zhu
,
M. Yang
,
G. Yang
,
Guenther Boden
,
L. Li
Journal of Endocrinological Investigation
2012
Corpus ID: 1820844
Background: The mechanisms regulating the anabolic response of the skeleton for recombinant human PTH (1–34) [rhPTH (1–34…
Expand
Highly Cited
2010
Highly Cited
2010
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis
J. Štěpán
,
D. Burr
,
+7 authors
I. Pávó
Osteoporosis International
2010
Corpus ID: 10119604
SummaryThe level of increased bone formation after 24 months of treatment with teriparatide (rhPTH (1–34), TPTD) is similar in…
Expand
2009
2009
Safety, tolerability and pharmacokinetic study of recombinant human parathyroid hormone [rhPTH (1-84)] in Chinese healthy volunteers
Qian Li
,
Jian Qiao
,
Jungang Deng
,
T. Zeng
,
P. Zhou
,
Weiyong Li
Journal of Huazhong University of Science and…
2009
Corpus ID: 195689054
SummaryThe current study was designed to determine the safety, tolerability and pharmacokinetic parameters of recombinant human…
Expand
2008
2008
Effect of systemic intermittent administration of human parathyroid hormone (rhPTH[1-34]) on the resistance to reverse torque in rabbit tibiae.
M. Corsini
,
F. N. Faraco
,
Alessandra A Pereira Castro
,
T. Onuma
,
W. Sendyk
,
J. Shibli
Journal of Oral Implantology
2008
Corpus ID: 20590594
The aim of this study was to evaluate the effect of intermittent administration of human parathyroid hormone [rhPTH (1-34)] on…
Expand
2008
2008
Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.
A. Anastasilakis
,
S. Polyzos
,
+5 authors
A. Avramidis
Endocrine journal
2008
Corpus ID: 20909601
INTRODUCTION Teriparatide (recombinant human PTH 1-34/TPTD) is an osteoanabolic agent available for osteoporosis treatment. The…
Expand
Highly Cited
2006
Highly Cited
2006
Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice.
M. Hurley
,
Y. Okada
,
+7 authors
J. Coffin
Biochemical and Biophysical Research…
2006
Corpus ID: 34341608
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE